112 related articles for article (PubMed ID: 17803958)
1. Homoisoflavanone inhibits retinal neovascularization through cell cycle arrest with decrease of cdc2 expression.
Kim JH; Kim KH; Kim JH; Yu YS; Kim YM; Kim KW; Kwon HJ
Biochem Biophys Res Commun; 2007 Nov; 362(4):848-52. PubMed ID: 17803958
[TBL] [Abstract][Full Text] [Related]
2. Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression.
Kim JH; Lee BJ; Kim JH; Yu YS; Kim MY; Kim KW
Eur J Pharmacol; 2009 Aug; 615(1-3):150-4. PubMed ID: 19470386
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
[TBL] [Abstract][Full Text] [Related]
4. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
5. Tubedown-1 (Tbdn-1) suppression in oxygen-induced retinopathy and in retinopathy of prematurity.
Gendron RL; Good WV; Miskiewicz E; Tucker S; Phelps DL; Paradis H
Mol Vis; 2006 Feb; 12():108-16. PubMed ID: 16518308
[TBL] [Abstract][Full Text] [Related]
6. Deguelin inhibits retinal neovascularization by down-regulation of HIF-1alpha in oxygen-induced retinopathy.
Kim JH; Kim JH; Yu YS; Shin JY; Lee HY; Kim KW
J Cell Mol Med; 2008 Dec; 12(6A):2407-15. PubMed ID: 18208562
[TBL] [Abstract][Full Text] [Related]
7. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic effect of caffeic acid on retinal neovascularization.
Kim JH; Lee BJ; Kim JH; Yu YS; Kim KW
Vascul Pharmacol; 2009 Oct; 51(4):262-7. PubMed ID: 19589397
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin 1 expression in retinal neovascularization in a mouse model of retinopathy of prematurity.
Xun W; Liu Y; Qing G; Xun X; Dongqing Z; Haixiang W
Prep Biochem Biotechnol; 2009; 39(2):208-17. PubMed ID: 19291583
[TBL] [Abstract][Full Text] [Related]
10. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model.
Igarashi T; Miyake K; Kato K; Watanabe A; Ishizaki M; Ohara K; Shimada T
Gene Ther; 2003 Feb; 10(3):219-26. PubMed ID: 12571629
[TBL] [Abstract][Full Text] [Related]
12. Hypercapnia- and trans-arachidonic acid-induced retinal microvascular degeneration: implications in the genesis of retinopathy of prematurity.
Leduc M; Kermorvant-Duchemin E; Checchin D; Sennlaub F; Sirinyan M; Kooli A; Lachapelle P; Chemtob S
Semin Perinatol; 2006 Jun; 30(3):129-38. PubMed ID: 16813971
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin-1 independent microvessel proliferation in a neonatal mouse model of oxygen-induced retinopathy.
Ruiz-Ederra J; Verkman AS
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4802-10. PubMed ID: 17898307
[TBL] [Abstract][Full Text] [Related]
14. The effect of L-thyroxine supplementation in a neonatal rat model of ROP.
Wren SM; Leske DA; Mutapcic L; Fautsch MP; Holmes JM
Curr Eye Res; 2006; 31(7-8):669-74. PubMed ID: 16877275
[TBL] [Abstract][Full Text] [Related]
15. Changes in pericytes and smooth muscle cells in the kitten model of retinopathy of prematurity: implications for plus disease.
Hughes S; Gardiner T; Baxter L; Chan-Ling T
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1368-79. PubMed ID: 17325186
[TBL] [Abstract][Full Text] [Related]
16. Combination angiostatic therapies: targeting multiple angiogenic pathways.
Friedlander M
Retina; 2009 Jun; 29(6 Suppl):S27-9. PubMed ID: 19553794
[TBL] [Abstract][Full Text] [Related]
17. How to overcome retinal neuropathy: the fight against angiogenesis-related blindness.
Jo DH; Kim JH; Kim JH
Arch Pharm Res; 2010 Oct; 33(10):1557-65. PubMed ID: 21052933
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic effect of deguelin on choroidal neovascularization.
Kim JH; Kim JH; Yu YS; Park KH; Kang HJ; Lee HY; Kim KW
J Pharmacol Exp Ther; 2008 Feb; 324(2):643-7. PubMed ID: 17967937
[TBL] [Abstract][Full Text] [Related]
19. Retinopathy of prematurity.
Chen J; Smith LE
Angiogenesis; 2007; 10(2):133-40. PubMed ID: 17332988
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of choroidal neovascularization by homoisoflavanone, a new angiogenesis inhibitor.
Kim JH; Kim JH; Yu YS; Jun HO; Kwon HJ; Park KH; Kim KW
Mol Vis; 2008 Mar; 14():556-61. PubMed ID: 18385791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
